Bhatia S, Jenney ME, Bogue MK, Rockwood TH, Feusner JH, Friedman DL, Robison LL, Kane RL. The Minneapolis-Manchester Quality of Life instrument: reliability and validity of the Adolescent Form. J Clin Oncol; 2002, 20(24): 4692-8.

Bhatia S, Sather HN, Heerema NA, Trigg ME, Gaynon PS, Robison LL. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood; 2002, 100(6): 1957-64.

Bhatia S, Sather HN, Pabustan OB, Trigg ME, Gaynon PS, Robison LL. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood; 2002, 99(12): 4257-64.

Bhatia S, Sklar C. Second cancers in survivors of childhood cancer. Nat Rev Cancer; 2002, 2(2): 124-32.

Blazer KR, Grant M, Sand SR, MacDonald DJ, Choi JJ, Nedelcu RA, Weitzel JN. Development of a cancer genetics education program for clinicians. J Cancer Educ; 2002, 17(2): 69-73.

Borneman T, Stahl C, Ferrell B, Smith D. The Concept of Hope in Family Caregivers of Cancer Patients at Home. Journal of Hospice and Palliative Nursing; 2002, 14(1): 21-33.

Chu PG, Chen YY, Molina A, Arber DA, Weiss LM. Recurrent B-cell neoplasms after Rituximab therapy: an immunophenotypic and genotypic study. Leuk Lymphoma; 2002, 43(12): 2335-41.

Chu PG, Ishizawa S, Wu E, Weiss LM. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol; 2002, 26(8): 978-88.

Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol; 2002, 15(1): 6-10.

Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology; 2002, 40(5): 403-39.

Cooke L, Grant M. Support for evidence-based practice. Semin Oncol Nurs; 2002, 18(1): 71-8.

Crans VH, Landaw EM, Bhatia S, Sandusky G, Moore TB, Sakamoto KM. Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia. Blood; 2002, 99(7): 2617-9.

Davies SM, Bhatia S, Ross JA, Kiffmeyer WR, Gaynon PS, Radloff GA, Robison LL, Perentesis JP. Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood; 2002, 100(1): 67-71.

Ferrell B, Ervin K, Smith S, Marek T, Melancon C. Family perspectives of ovarian cancer. Cancer Pract; 2002, 10(6): 269-76.

Ferrell B, Grant M, Borneman T, Juarez G, Virani R. Strategies for Effective Continuing Education by Oncology Nurses. Oncology Nursing Forum; 2002, 29(6): 907-909.

Ferrell B, Juarez G. Cancer pain education for patients and the public. Journal of Pain and Symptom Management; 2002, 23(4): 329-336.

Ferrell BR, Borneman T. Community implementation of home care palliative care education. Cancer Pract; 2002, 10(1): 20-7.

Ferrell BR, Coyle N. An overview of palliative nursing care. Am J Nurs; 2002, 102(5): 26-31; quiz 32.

Gaal K, Weiss LM, Chen WG, Chen YY, Arber DA. Epstein-Barr virus nuclear antigen (EBNA)-1 carboxy-terminal and EBNA-4 sequence polymorphisms in nasal natural killer/T-cell lymphoma in the United States. Lab Invest; 2002, 82(7): 957-62.

Grant M, Hanson J. Issues and Opportunities in Quality End-of-Life Care. Journal of Oncology Management; 2002;  : 22-24.

Heinmoller E, Liu Q, Sun Y, Schlake G, Hill KA, Weiss LM, Sommer SS. Toward efficient analysis of mutations in single cells from ethanol-fixed, paraffin-embedded, and immunohistochemically stained tissues. Lab Invest; 2002, 82(4): 443-53.

Herzog JS, Jancis E, Liao S, Somlo G, Weitzel J. Restriction endonuclease fingerprinting enhanced conformation sensitive gel electrophoresis (REF-CSGS) in the analysis of BRAC1 Exong 11 mutations in a high risk breast cancer cohort. Human Mutation; 2002; 19: 656-663.

Lamont J, Kakuda JT, Smith DD, Wagman LD, Grannis FW. Systematic postoperative follow-up in patients with non-small lung cancer for detecting second primary lung cancer in stage 1A. Arch Surg; 2002; 137: 935-940.

MacDonald DJ. Women's decisions regarding management of breast cancer risk. Medsurg Nurs; 2002, 11(4): 183-6.

MacDonald DJ, Choi J, Ferrell B, Sand S, McCaffrey S, Blazer K, Grant M, Weitzel J. Concerns of women presenting to a comprehensive cancer center for genetic cancer risk assessment. Journal of Medical Genetics; 2002; 39: 526-530.

McCahill L, Ferrell B. Palliative surgery for cancer pain. West J Med; 2002, 176(2): 107-10.

McCahill LE, Krouse R, Chu D, Juarez G, Uman GC, Ferrell B, Wagman LD. Indications and use of palliative surgery-results of Society of Surgical Oncology survey. Ann Surg Oncol; 2002, 9(1): 104-12. CCPS|DCT*

McCahill LE, Krouse RS, Chu DZ, Juarez G, Uman GC, Ferrell BR, Wagman LD. Decision making in palliative surgery. J Am Coll Surg; 2002, 195(3): 411-22; discussi

Narod SA, Dube M, Klijn J, Lubinski J, Lynch HT, Ghadirian P, Provencher D, Heimdahl K, Moller P, Isaacs C, Weber B, Friedman E, Gershoni BR, Rennert G, Pasini B, Wangner T, Daly M, Garber JE, Neuhausen S, Robson M, Ainsworth P, Olsson H, Evans G, Osborne M, Couch F, Foulkes W, Warner E, Kim SC, Olopade O, Tung N, Saal H, Weitzel J, Nerajver S, Stoppa LD, Jernstrom H, Sun P, Brunet J. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 carriers. Journal of National Cancer Institute; 2002; 94: 1773-1779.

Otis GS, Sherman R, Perez M, Baird RP. An integrated psychosocial-spiritual model for cancer pain management. Cancer Pract; 2002; 10 Suppl 1: S58-65.

Perez MA, Skinner EC, Meyerowitz BE. Sexuality and intimacy following radical prostatectomy: Patient and partner perspectives. Health Psychol; 2002, 21(3): 288-93.

Pfeifer G, Yoon JH, Liu L, Tommasi S, Wilczynski S, Dammann R. Methylation of the RASSF1A gene in human cancers. Biol Chem; 2002, 383(6): 907-14.

Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK, Favera RD, Delsol G, De WP, Falini B, Gascoyne RD, Gaulard P, Gatter KC, Isaacson PG, Jaffe ES, Kluin P, Knowles DM, Mason DY, Mori S, Muller HH, Piris MA, Ralfkiaer E, Stein H, Su IJ, Warnke RA, Weiss LM. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology; 2002, 41(1): 1-29.

Schwarz RE, Hillebrand G, Peralta EA, Chu D, Weiss LM. Long-term survival after radical operations for cancer treatment-induced sarcomas: How two survivors invite reflection on oncologic treatment concepts. Am J Clin Oncol; 2002, 25(3): 244-7.

Solano AR, Dourisboure RJ, Weitzel J, Podesta EJ. A cautionary note: false homozygosity for BRCA2 6174delT mutation resulting from a single nucleotide polymorphism masking the wt allele. Eur J Hum Genet; 2002, 10(6): 395-7.

Sommer S, Buzin C, Jung M, Zheng J, Liu Q, Jeong SJ, Moulds J, Nguyen VQ, Feng J, Bennett WP, Dritschilo A. Elevated frequency of ATM Gene Mutations in Breast Cancer Relative to Ethnically Matched Controls. Cancer Genet Cytogenet; 2002; 134: 25-32.

Wang J, Weiss LM, Chang KL, Slovak ML, Gaal K, Forman SJ, Arber DA. Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. Cancer; 2002, 94(5): 1522-31.

Durrin LK, Krontiris TG. The thymocyte-specific MAR binding protein, SATB1, interacts in vitro with a novel variant of DNA-directed RNA polymerase II, subunit 11. Genomics; 2002, 79(6): 809-17.

Foulkes WD, Thiffault I, Gruber SB, Horwitz M, Hamel N, Lee C, Shia J, Markowitz A, Figer A, Friedman E, Farber D, Greenwood CM, Bonner JD, Nafa K, Walsh T, Marcus V, Tomsho L, Gebert J, Macrae FA, Gaff CL, Bressac dP, Gregersen PK, Weitzel JN, Gordon PH, MacNamara E, King MC, Hampel H, de lC, Boyd J, Offit K, Rennert G, Chong G, Ellis NA. The founder mutation MSH2*1906G -> C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. American Journal of Human Genetics; 2002, 71(6): 1395-1412.